Yahoo
Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.
Market Cap
8.817T
Market Weight
9.96%
Industries
11
Companies
1128
Healthcare S&P 500 ^GSPC
Chart Range Bar
Loading chart for Healthcare

Day Return

Sector
2.01%
S&P 500
0.38%

YTD Return

Sector
21.84%
S&P 500
11.87%

1-Year Return

Sector
31.09%
S&P 500
11.96%

3-Year Return

Sector
57.52%
S&P 500
87.37%

5-Year Return

Sector
30.23%
S&P 500
67.52%

Note: Sector performance is calculated based on the previous closing price of all sector constituents

Industries in This Sector

Select an Industry for a Visual Breakdown

Industry
Market Weight
YTD Return
All Industries
100.00%
21.84%
Drug Manufacturers - General
43.28%
39.59%
Biotechnology
12.65%
21.40%
Diagnostics & Research
11.02%
24.15%
Medical Devices
9.03%
-9.09%
Healthcare Plans
8.64%
22.37%
Medical Instruments & Supplies
5.62%
-5.69%
Medical Distribution
2.77%
8.06%
Drug Manufacturers - Specialty & Generic
2.76%
26.81%
Medical Care Facilities
2.75%
10.49%
Health Information Services
1.48%
-6.84%
Pharmaceutical Retailers
0.00%
-34.33%

Note: Percentage % data on heatmap indicates Day Return

Largest Companies in This Sector

View More
Table View
Heatmap View
Name
Last Price
1Y Target Est.
Market Weight
Market Cap
Day Change %
YTD Return
Avg. Analyst Rating
1,373.09 1,333.72 14.58% 1.224T +6.58% +27.77%
Buy
274.43 279.41 7.87% 660.638B +1.25% +32.61%
Buy
289.22 283.19 6.09% 511.086B +1.13% +26.58%
Buy
406.67 476.64 4.35% 365.02B -0.11% +23.19%
Buy
147.69 159.76 4.34% 364.377B +4.80% +40.31%
Buy
709.96 750.92 3.13% 262.504B +0.82% +22.52%
Strong Buy
458.43 397.32 2.95% 247.839B +1.46% +40.06%
Hold
161.35 160.19 2.38% 200.073B +1.35% +31.46%
Buy
103.94 118.52 2.16% 181.044B +1.27% -17.04%
Buy
29.68 29.26 2.01% 169.166B +0.78% +19.20%
Buy

Investing in the Healthcare Sector

Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds

ETF Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
183.41 43.393B 0.08% +18.48%
340.87 21.809B 0.09% +18.42%
217.20 11.197B 0.44% +28.70%
157.87 10.358B 0.35% +29.48%
111.43 4.316B 0.38% +14.40%

Mutual Fund Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
91.87 38.313B 0.27% +6.52%
217.83 38.313B 0.27% +6.48%
167.33 21.809B 0.09% +16.25%
137.99 16.876B 0.00% +3.58%
11.44 16.876B 0.00% +2.94%

Healthcare Research

View More

Discover the Latest Analyst and Technical Research for This Sector

  • Analyst Report: GSK plc

    In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

    Rating
    Price Target
  • Analyst Report: Centene Corp

    Centene Corp. is an international healthcare company. Based in St. Louis, Centene offers services to government-sponsored and commercial healthcare providers, with an emphasis on underinsured and uninsured individuals. It is the largest Medicaid managed care organization in the U.S. and a leading provider of insurance under the Affordable Care Act. Its Specialty Services segment provides a range of healthcare products and services to managed care members and other customers.

    Rating
    Price Target
  • Analyst Report: Biogen Inc

    Biogen Inc. is a biotech company that develops, manufactures, and sells therapies for treating neurological and neurodegenerative diseases. The company is the market leader in MS drugs and launched the first approved treatments for SMA and AD. The company also sells products that treat plaque psoriasis, non-Hodgkin's lymphoma, lymphocytic leukemia, and rheumatoid arthritis. Current research continues on MS and has expanded to include neuroimmunology, ophthalmology, lupus, and other neuromuscular and movement disorders. Founded in 1978, the company is located in Cambridge, Massachusetts; employs 7,500 people; and is a component of the S&P 500.

    Rating
    Price Target
  • Technical Assessment: Bullish in the Intermediate-Term

    Yesterday in this space, we featured some well-known quotes from technical thought leaders. Today, we complete our lookback for turbulent times with more meaningful advice, complied by Argus' CMT Mark Arbeter.

Healthcare News

Mobilize your Website
View Site in Mobile | Classic
Share by: